Teva, the world's largest maker of generic pharmaceuticals, has had its generic version of AstraZenca's breast cancer drug Arimidex approved for sale in the US, to treat breast cancer in post-menopausal women.
The FDA also approved Venlafaxine HC1 ER capsules, Teva's new generic version of antidepressant Effexor XR. Effexor treats anxiety, panic attacks, and depression. Teva has been awarded a 180-day exclusivity period, as the first to file an Abbreviated New Drug Application (ANDA).
On June 29, Teva stocks rose on the 1.73% on the NASDAQ.